NOVO — Juli 2022
-
Test
-
Novo/Sydbank: Svært at se konkurrence fra californisk insulininitiativ
Californiens hensigt om at producere insulin til delstatens befolkning kan næppe hamle op med de store insulinproducenter. Med al sandsynlighed vil delstatens insulin både være dyrere og baseret på forskning af ældre dato.
Derfor vil initiativet næppe påvirke Novo Nordisk, mener Søren Løntoft Hansen, der er senioranalytiker i Sydbank, til MarketWire.
-
-
Novo Nordisk A/S: Phase 3 data for concizumab show 86% reduction in treated bleeds in haemophilia A or B with inhibitor s https://www.proinvestor.com/boards/104383s
-
USD styrkelse er godt for Novo Nordisk og co - i 2023 https://www.proinvestor.com/boards/104406
-
-
Novo/Jyske: Udsigt til stærkt andet kvartal med mulig opjustering
https://www.proinvestor.com/investornyt/849524/novo-jyske-udsigt-til-staerkt-andet-kvartal-med-mulig-opjustering -
ANALYSIS-Bruised investors seek shelter in U.S. healthcare stocks https://www.proinvestor.com/investornyt/849645/analysis-bruised-investors-seek-shelter-in-us-healthcare-stocks
-
Novo: Wegovy kan blive førstevalg i USA, men det er dyrt https://www.proinvestor.com/investornyt/850027/novo-wegovy-kan-blive-forstevalg-i-usa-men-det-er-dyrt-gent
-
Dejligt med Novo i dag. Forventning om opjustering.
-
Min største position. Jeg er en glad mand.
-
Samme her..så jeg er også mega glad:-)
-
og den fortsætter åbenbart....
-
Video til weekenden: Spændende Biotech-aktier: https://www.proinvestor.com/boards/104411/
-
Fantastisk.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind